Zappitelli Sabrina, D'Alatri Laura, Ciucci Allesandra, Raucci Giuseppe, Faiella Angela, Gabrielli Meri, Parlani Massimo, Bressan Alessandro, Maggi Carlo A, Goso Cristina, Rotondaro Luigi
Menarini Biotech srl, Pomezia, Roma, Italy.
Mol Biotechnol. 2003 Mar;23(3):189-202. doi: 10.1385/MB:23:3:189.
We describe an expression system for high-yield production of recombinant soluble human FasL (rsh- FasL) in CHO cells. After one round of selection for gene amplification, cell lines producing rsh-FasL up to 60 microg/L x 10(6) cells in 24 h were obtained. Cell lines were grown in protein-free medium as suspension cultures. The protein secreted into growth medium was purified by immunoaffinity. The rsh-FasL thus obtained was further fractionated by gel filtration and a form of approx 140 kDa was isolated and characterized. Mass spectral analysis yielded a main peak of 28,321.15 Da, while, although to a lesser extent, dimeric and trimeric forms were also detected according to the described oligomerized state of native FasL. Our procedure permits consistent production of biologically active rsh-FasL as shown in tests on FasL-sensitive cells and in in vitro binding assays.
我们描述了一种在CHO细胞中高产重组可溶性人FasL(rsh-FasL)的表达系统。经过一轮基因扩增筛选后,获得了在24小时内每10^6个细胞可产生高达60微克/升rsh-FasL的细胞系。细胞系在无蛋白培养基中作为悬浮培养物生长。分泌到生长培养基中的蛋白质通过免疫亲和法进行纯化。由此获得的rsh-FasL进一步通过凝胶过滤进行分级分离,分离并鉴定出一种约140 kDa的形式。质谱分析产生了一个28,321.15 Da的主峰,同时,根据天然FasL所述的寡聚化状态,虽然程度较小,但也检测到了二聚体和三聚体形式。如在对FasL敏感细胞的测试和体外结合试验中所示,我们的方法能够持续产生具有生物活性的rsh-FasL。